TY  - JOUR

T1  - Open multicentre study of the P2T receptor antagonist AR-C69931MX assessing safety, tolerability and activity in patients with acute coronary syndromes.

JO  - Thromb Haemost

PY  - 2001/03/01

AU  - Storey RF

AU  - Oldroyd KG

AU  - Wilcox RG

ED  - 

VL  - 85

IS  - 3

SP  - 401

EP  - 407

Y2  - 2024/12/22

ER  -